USE OF A MAST CELL ACTIVATION OR DEGRANULATION BLOCKING AGENT IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF A PATIENT SUBJECTED TO THROMBOLYSES
摘要
The invention concerns the use of a mast cell activation- or degranulation-blocking agent in the manufacture of a medicament for preventing and treating cerebral complications caused by thrombolytic treatment. The invention also relates to treatment of patients suffering from cerebral complications associated with thrombolysis. Further, the invention provides thrombolytic compositions comprising a mast cell degranulation-blocking and/or mast cell activation-blocking agent present in a therapeutically effective amount to prevent or reduce any cerebral complications caused by the active thrombolytic component.
申请公布号
WO2004071532(A1)
申请公布日期
2004.08.26
申请号
WO2004FI00072
申请日期
2004.02.13
申请人
LICENTIA OY;LINDSBERG, PERTTU, J.;KARJALAINEN-LINDSBERG, MARJA-LIISA;TATLISUMAK, TURGUT;STRBIAN, DANIEL;KOVANEN, PETRI
发明人
LINDSBERG, PERTTU, J.;KARJALAINEN-LINDSBERG, MARJA-LIISA;TATLISUMAK, TURGUT;STRBIAN, DANIEL;KOVANEN, PETRI